Show overview
Check. Change. Control. Cholesterol™ launched in 2021 and has put out 11 episodes in the time since. That works out to roughly 5 hours of audio in total. Releases follow a roughly quarterly cadence.
Episodes typically run twenty to thirty-five minutes — most land between 20 min and 27 min — and the run-time is fairly consistent across the catalogue. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Health & Fitness show.
The catalogue appears to be on hiatus or wound down — the most recent episode landed 3.8 years ago, with no new episodes in over a year. The busiest year was 2021, with 8 episodes published. Published by Selena Smith.
From the publisher
This podcast series for healthcare professionals offers expert insights and discussion on the prevalence of high cholesterol. Learn about improving cholesterol management with a healthy lifestyle and discuss treatment plans.
Latest Episodes
ASCVD Series - Part 3-The Next Top Model: Activating & Improving Systems of Care
Listen as Dr. Howard Haft & Dr. Tracy Yu-Ping Wang discuss techniques on how to improve the transition of care for ASCVD patients into the outpatient setting – and how social determinants of health play a factor in treatment plans.
ASCVD Series - Part 2-Looking Ahead in ASCVD
One of the biggest challenges for newly diagnosed ASCVD patients is medication adherence. Listen as Dr. Michelle Chu, PharmD discusses how to work with patients who are struggling to adapt to their new lifestyle and the importance of integrating their care givers into the conversation.
ASCVD Series - Part 1-The Importance of Bridging the Gap in Lipid Management
How does the equity gap play a role in lipid management? Join us as we interview Dr. Keith Ferdinand on the importance of recognizing & addressing implicit bias in cardiovascular care, and what he is doing at Tulane University to train future physicians in this subject matter.
Statin and Non-Statin Drugs
Statins are the cornerstone of lipid lowering drugs. Listen as Drs. Natarajan, Michos, and Kara discuss the role of statins for cardiovascular disease prevention as well as new incorporation of some non-statin cholesterol-lowering medications in 2018 AHA/ACC Cholesterol Guidelines.
Coronary Calcification (CAC Score)
A deep dive discussion between Drs. Pradeep Natarajan, Ron Blankstein and Khurram Nasir in assessment of Coronary artery calcium (CAC) to help guide prognosis and management. In this podcast learn the role of CAC score.
Uses of PCSK9 Inhibitors
Listen as Drs. Ferguson and Musunuru review history and uses of PCSK9 inhibitors and how these drugs can transform cardiovascular medicine.
New Discoveries in Cholesterol Metabolism
Despite medications to reduce risk of heart cardiovascular disease; heart disease is still the number one leading cause of death in the United States as well as around the world. Listen to Drs. Ferguson and Musunuru as they review new discoveries in cholesterol metabolism and explore why researchers are continuing to study cholesterol metabolism very intensively.
ASCVD Risk Calculator
Atherosclerotic Cardiovascular Disease (ASCVD). risk calculator is a tool that enables healthcare providers and patients to estimate ten-year and lifetime risk of ASCVD. Listen as Dr. Virani explores the reasons why should healthcare professionals should perform ASCVD risk assessment and how the ASCVD Risk Calculator can be used.
Familial Hypercholesterolemia
What is the prevalence of familial hypercholesterolemia? Learn more as Drs. Mehta and Orringer examine the 2018 cholesterol guidelines and how familial hypercholesterolemia and its treatment fall into the new guideline.
Women's CVD and the Cholesterol Guidelines
Cardiovascular disease is the leading cause of death for women in the US and worldwide. Listen as Drs. Mehta, Braun, and Lundberg discuss the importance of adding women-specific factors in the guideline and focus on many important areas common in women's health that includes rheumatologic disorders, such as rheumatoid arthritis, systemic lupus erythematosus, but also unique factors to women such as pregnancy complications.
New Guideline Changes
The 2018 AHA/ACC cholesterol guideline address the management of patients with high blood cholesterol and other disorders, and risks for atherosclerotic cardiovascular disease. Listen as Dr. Pradeep Natarajan discusses the important changes in 2018 AHA/ACC Cholesterol Guidelines and comparing them to the 2013 cholesterol guideline.